Zai Lab is a biopharmaceutical company dedicated to discovering, developing and commercializing innovative medicines. The Company's vision is to address the largest unmet medical needs and transform patients’ lives around the world. Zai Lab takes a unique approach to combine both in-licensed products and internal R&D to achieve a rich pipeline.
TypePublic
HQShanghai, CN
Founded2013
Size (employees)21 (est)
Websitezailaboratory.com
ZAI Lab was founded in 2013 and is headquartered in Shanghai, CN
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at ZAI Lab

Samantha Du

Samantha Du

CEO

ZAI Lab Office Locations

ZAI Lab has offices in Suzhou, Chaoyang and Shanghai
Show all (3)
Report incorrect company information

ZAI Lab Financials and Metrics

ZAI Lab Revenue

USD

Net income (FY, 2016)

(37.5m)

EBIT (FY, 2016)

(38.5m)

Market capitalization (15-Oct-2018)

807.2m

Closing stock price (15-Oct-2018)

16.0

Cash (31-Dec-2016)

83.9m
ZAI Lab's current market capitalization is $807.2 m.
USDFY, 2015FY, 2016

General and administrative expense

2.8m6.4m

R&D expense

13.6m32.1m

Operating expense total

13.6m32.1m

EBIT

(16.3m)(38.5m)
USDFY, 2015FY, 2016

Cash

13.2m83.9m

Total Assets

13.9m88.9m

Current Liabilities

3.9m5.2m

Non-Current Liabilities

62.0k778.0k
USDFY, 2015FY, 2016

Cash From Operating Activities

(11.5m)(32.2m)

Cash From Investing Activities

(738.0k)(2.7m)

Cash From Financing Activities

18.3m106.2m

Net Change in Cash

6.0m70.8m
USDY, 2016

Financial Leverage

-1.7 x
Show all financial metrics
Report incorrect company information

ZAI Lab Company Life and Culture

Report incorrect company information